Neuropsychopharmacology Reports (Mar 2023)
Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders
- Kentaro Fukumoto,
- Fumitoshi Kodaka,
- Naomi Hasegawa,
- Hiroyuki Muraoka,
- Hikaru Hori,
- Kayo Ichihashi,
- Yuka Yasuda,
- Hitoshi Iida,
- Kazutaka Ohi,
- Shinichiro Ochi,
- Kenta Ide,
- Naoki Hashimoto,
- Masahide Usami,
- Toshinori Nakamura,
- Hiroshi Komatsu,
- Tsuyoshi Okada,
- Tatsuya Nagasawa,
- Ryuji Furihata,
- Kiyokazu Atake,
- Mikio Kido,
- Saya Kikuchi,
- Hirotaka Yamagata,
- Taishiro Kishimoto,
- Manabu Makinodan,
- Tadasu Horai,
- Masahiro Takeshima,
- Chika Kubota,
- Takeshi Asami,
- Eiichi Katsumoto,
- Akitoyo Hishimoto,
- Toshiaki Onitsuka,
- Junya Matsumoto,
- Kenichiro Miura,
- Hisashi Yamada,
- Norio Yasui‐Furukori,
- Koichiro Watanabe,
- Ken Inada,
- Kotaro Otsuka,
- Ryota Hashimoto
Affiliations
- Kentaro Fukumoto
- Department of Neuropsychiatry, School of Medicine Iwate Medical University Iwate Japan
- Fumitoshi Kodaka
- Department of Psychiatry The Jikei University School of Medicine Tokyo Japan
- Naomi Hasegawa
- Department of Pathology of Mental Diseases, National Institute of Mental Health National Center of Neurology and Psychiatry Kodaira Japan
- Hiroyuki Muraoka
- Department of Psychiatry Kitasato University School of Medicine Sagamihara Japan
- Hikaru Hori
- Department of Psychiatry, Faculty of Medicine Fukuoka University Fukuoka Japan
- Kayo Ichihashi
- Department of Neuropsychiatry University of Tokyo Hospital Tokyo Japan
- Yuka Yasuda
- Department of Pathology of Mental Diseases, National Institute of Mental Health National Center of Neurology and Psychiatry Kodaira Japan
- Hitoshi Iida
- Department of Psychiatry, Faculty of Medicine Fukuoka University Fukuoka Japan
- Kazutaka Ohi
- Department of Psychiatry Gifu University Graduate School of Medicine Gifu Japan
- Shinichiro Ochi
- Department of Neuropsychiatry, Molecules and Function Ehime University Graduate School of Medicine Ehime Japan
- Kenta Ide
- Department of Hospital Pharmacy Hospital of University of Occupational and Environmental Health Kitakyushu Japan
- Naoki Hashimoto
- Department of Psychiatry Hokkaido University Graduate School of Medicine Hokkaido Japan
- Masahide Usami
- Department of Child and Adolescent Psychiatry, Kohnodai Hospital National Center for Global Health and Medicine Tokyo Japan
- Toshinori Nakamura
- Department of Psychiatry Shinshu University School of Medicine Matsumoto Japan
- Hiroshi Komatsu
- Department of Psychiatry Tohoku University Hospital Sendai Japan
- Tsuyoshi Okada
- Department of Psychiatry Jichi Medical University Shimotsuke Japan
- Tatsuya Nagasawa
- Department of Neuropsychiatry Kanazawa Medical University Uchinada Japan
- Ryuji Furihata
- Agency for Student Support and Disability Resources Kyoto University Kyoto Japan
- Kiyokazu Atake
- Nippon Telegraph and Telephone West Corporation Kyushu Health Administration Center Fukuoka Japan
- Mikio Kido
- Kido Clinic Toyama Japan
- Saya Kikuchi
- Department of Psychiatry Tohoku University Hospital Sendai Japan
- Hirotaka Yamagata
- Division of Neuropsychiatry, Department of Neuroscience Yamaguchi University Graduate School of Medicine Yamaguchi Japan
- Taishiro Kishimoto
- Hills Joint Research Laboratory for Future Preventive Medicine and Wellness Keio University School of Medicine Tokyo Japan
- Manabu Makinodan
- Department of Psychiatry Nara Medical University Kashihara Japan
- Tadasu Horai
- Department of Psychiatry Kobe University Graduate School of Medicine Kobe Japan
- Masahiro Takeshima
- Department of Neuropsychiatry Akita University Graduate School of Medicine Akita City Japan
- Chika Kubota
- National Center Hospital National Center of Neurology and Psychiatry Kodaira Japan
- Takeshi Asami
- Department of Psychiatry Yokohama City University Graduate School of Medicine Yokohama Japan
- Eiichi Katsumoto
- Katsumoto Mental Clinic Osaka Japan
- Akitoyo Hishimoto
- Department of Psychiatry Yokohama City University Graduate School of Medicine Yokohama Japan
- Toshiaki Onitsuka
- Department of Neuroimaging Psychiatry, Graduate School of Medical Sciences Kyushu University Fukuoka Japan
- Junya Matsumoto
- Department of Pathology of Mental Diseases, National Institute of Mental Health National Center of Neurology and Psychiatry Kodaira Japan
- Kenichiro Miura
- Department of Pathology of Mental Diseases, National Institute of Mental Health National Center of Neurology and Psychiatry Kodaira Japan
- Hisashi Yamada
- Department of Pathology of Mental Diseases, National Institute of Mental Health National Center of Neurology and Psychiatry Kodaira Japan
- Norio Yasui‐Furukori
- Department of Psychiatry Dokkyo Medical University School of Medicine Mibu Japan
- Koichiro Watanabe
- Department of Neuropsychiatry, School of Medicine Kyorin University Mitaka Japan
- Ken Inada
- Department of Psychiatry Kitasato University School of Medicine Sagamihara Japan
- Kotaro Otsuka
- Department of Neuropsychiatry, School of Medicine Iwate Medical University Iwate Japan
- Ryota Hashimoto
- Department of Pathology of Mental Diseases, National Institute of Mental Health National Center of Neurology and Psychiatry Kodaira Japan
- DOI
- https://doi.org/10.1002/npr2.12301
- Journal volume & issue
-
Vol. 43,
no. 1
pp. 33 – 39
Abstract
Abstract Aim Treatment guidelines are designed to assist patients and health care providers and are used as tools for making treatment decisions in clinical situations. The treatment guidelines of the Japanese Society of Mood Disorders establish treatment recommendations for each severity of depression. The individual fitness score (IFS) was developed as a simple and objective indicator to assess whether individual patients are practicing treatment by the recommendations of the depression treatment guidelines of the Japanese Society of Mood Disorders. Methods The EGUIDE project members determined the IFS through the modified Delphi method. In this article, the IFS was calculated based on the treatment of depressed patients treated and discharged between 2016 and 2020 at facilities participating in the EGUIDE project. In addition, we compared scores at admission and discharge. Results The study included 428 depressed patients (mild n = 22, moderate/severe n = 331, psychotic n = 75) at 57 facilities. The mean IFS scores by severity were statistically significantly higher at discharge than at admission with moderate/severe depression (mild 36.1 ± 34.2 vs. 41.6 ± 36.9, p = 0.49; moderate/severe 50.2 ± 33.6 vs. 55.7 ± 32.6, p = 2.1 × 10–3; psychotic 47.4 ± 32.9 versus 52.9 ± 36.0, p = 0.23). Conclusion We developed the IFS based on the depression treatment guideline, which enables us to objectively determine how close the treatment is to the guideline at the time of evaluation in individual cases. Therefore, the IFS may influence guideline‐oriented treatment behavior and lead to the equalization of depression treatment in Japan, including pharmacotherapy.
Keywords